"The purpose of Lung Cancer Frontiers is to acquire and disseminate new knowledge about lung cancer and how it can be most quickly and effectively diagnosed and treated."
History of Lung Cancer Frontiers
Dr. Thomas L. Petty founded Lung Cancer Frontiers in 1996, when he saw a need to stimulate interest in lung cancer among health care providers. Primarily written for pulmonologists, this newsletter is dedicated to advancing knowledge about lung cancer, with an emphasis on early diagnosis and treatment. In April 2008, National Jewish Health became the new home of Lung Cancer Frontiers. In January 2010, Dr. Jeffrey A. Kern, Professor of Medicine and Chief of the Division of Oncology at National Jewish Health, became Editor in Chief of Lung Cancer Frontiers.
Lung Cancer Frontiers Editorial Board
- Chronic Obstructive Pulmonary Disease as a Casual Pathway to Lung Cancer, by Brian Sandri, PhD and Chris Wendt, MD
- Selections from the Peer-Reviewed Literature, by Gary Schwartz, MD and Malcom V. Brock, MD
- Lung Cancer in the Military: An Opportunity for Change, by Barbara G. Campling, MD, FRCPC
- Selections from the Peer-Reviewed Literature, by Hiram Rivas-Perez, MD, and Patrick Nana-Sinkam, MD
- Advances in Radiological Characterization of Lung Cancer and Lung Nodules, by Jessica C. Sieren, PhD and John D. Newell, Jr., MD, FACR, FCCP, FASER
- Selections from the Peer-Reviewed Literature, by Kendra Hammond, MD and Ali I. Musani, MD, FCCP
- Racial Disparities in Lung Cancer: Here and Now..., by Christopher S. Lathan, MD, MS, MPH
- Selections from the Peer-Reviewed Literature, by York E. Miller, MD
- Breath Volatile Metabolic Biomarkers of Lung Cancer, by Peter Mazzone, MD, MPH, FCCP
- Selections from the Peer-Reviewed Literature, by Ignacio I. Wistuba, MD